Glycitop-MR 30 Tablet
Marketer
Healing Pharma India Pvt Ltd
Salt Composition
Gliclazide (30mg)
Overview Glycitop-MR 30 Tablet
Diabetol-XR 30mg tablets manage type 2 diabetes in adults. A sulfonylurea, it regulates blood glucose, mitigating diabetes complications like vision impairment and kidney disease. This medication might be used alone or with other treatments and should be taken with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust over time. Continued use, even with controlled blood sugar, is crucial; abrupt cessation risks elevated glucose levels and potentially severe consequences such as nerve damage, limb loss, and vision problems. Diabetol-XR 30mg is just one element of a comprehensive diabetes plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include digestive upset and hypoglycemia (low blood sugar). Learn to identify hypoglycemia symptoms (sweating, dizziness, trembling, headache) and manage them promptly; regular meals and readily available glucose (e.g., juice, sweets) are essential. Alcohol increases hypoglycemia risk and should be limited. Weight gain may occur. This medicine is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any pre-existing heart, thyroid, or hormonal conditions before starting. Consult your physician if pregnant or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests, will be necessary.
Primary Ingredients of Glycitop-MR 30 Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Glycitop-MR 30 Tablet
Managing Type 2 Diabetes
Major Benefits of Glycitop-MR 30 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycitop-MR 30 Tablet whole; do not chew, crush, or fracture it. Administer this medication with food.
Common Side effects of Glycitop-MR 30 Tablet:
- Hypoglycemia (low blood glucose level)
- Weight gain
- Flatulence
- Diarrhea
- Headache
- Nausea
- Dizziness
How to use Glycitop-MR 30 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glycitop-MR 30 Tablet with a meal.
How Glycitop-MR 30 Tablet works:
This drug treats diabetes by stimulating the pancreas to produce more insulin, thus reducing blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycitop-MR 30 Tablet and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glycitop-MR 30 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Use of Glycitop-MR 30 Tablet while breastfeeding is contraindicated due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneySAFE IF PRESCRIBED
Glycitop-MR 30 tablets are considered safe for patients with kidney impairment; dose modification is not typically necessary. Nevertheless, its use is prohibited in individuals exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Glycitop-MR 30 tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Glycitop-MR 30 Tablet :
Should you forget a Glycitop-MR 30 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glycitop-MR 30 Tablet
| Label | Value |
|---|---|
| Chemical Category | Second-generation sulfonylurea |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | Sulfonylureas: Insulin Stimulators |




